Valmark Advisers, Inc. Moderna, Inc. Transaction History
Valmark Advisers, Inc.
- $7.6 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding MRNA
# of Institutions
849Shares Held
267MCall Options Held
28.5MPut Options Held
35.2M-
Vanguard Group Inc Valley Forge, PA41.2MShares$1.09 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$675 Million0.07% of portfolio
-
Baillie Gifford & CO21.8MShares$577 Million0.44% of portfolio
-
State Street Corp Boston, MA17.3MShares$456 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$234 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.3B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...